These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7535829)

  • 41. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 43. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poliovirus intrahost evolution is required to overcome tissue-specific innate immune responses.
    Xiao Y; Dolan PT; Goldstein EF; Li M; Farkov M; Brodsky L; Andino R
    Nat Commun; 2017 Aug; 8(1):375. PubMed ID: 28851882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating.
    Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV
    J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors.
    Mandl S; Hix L; Andino R
    J Virol; 2001 Jan; 75(2):622-7. PubMed ID: 11134275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus.
    Liu S; Song D; Bai H; Lu W; Dai X; Hao C; Zhang Z; Guo H; Zhang Y; Li X
    J Med Virol; 2017 Dec; 89(12):2075-2083. PubMed ID: 28786502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the neutralization of poliovirus by fecal immunoglobulins. The development of intestinal IgA antibodies following oral poliovirus immunization.
    Keller R; Dwyer JE
    Prog Immunobiol Stand; 1970; 4():316-22. PubMed ID: 4320518
    [No Abstract]   [Full Text] [Related]  

  • 50. New poliovirus vaccine schedules.
    Zhang Q; Leppold C; Shao Y; Mura Y; Tanimoto T
    Lancet; 2016 Nov; 388(10059):2477-2478. PubMed ID: 27871742
    [No Abstract]   [Full Text] [Related]  

  • 51. [Precipitation antibodies against poliovirus in patients with poliomyelitis].
    Ruiz-Gómez J; Bustamante ME
    Arch Invest Med (Mex); 1977; 8(2):103-12. PubMed ID: 199122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS; Nossik NN; Bindu ; Vijayan P; Raghavan NG; Paul SS
    Bull World Health Organ; 1973; 48(2):195-8. PubMed ID: 4352611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Virologic and serologic study on subjects vaccinated with Sabin vaccine, living in a community].
    Andreoni G; Curatolo D; Cervini E; Rocchi G; Velli V
    Boll Ist Sieroter Milan; 1966; 45(5-6):236-49. PubMed ID: 9190150
    [No Abstract]   [Full Text] [Related]  

  • 56. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
    Pasamontes L; Egger D; Bienz K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey.
    Trivello R; Farisano G; Bonello C; Moschen ME; Baldo V; Majori S; Moretti G; Marin V; Piron L; Renzulli G
    Ann Clin Lab Sci; 1994; 24(6):542-7. PubMed ID: 7847782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low oral poliovirus vaccine immunogenicity in developing countries.
    Orenstein WA; Garon JR
    Lancet Infect Dis; 2016 Aug; 16(8):868-9. PubMed ID: 27156190
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3.
    Böthig B; Danes L; Dittmann S
    Bull World Health Organ; 1990; 68(5):597-600. PubMed ID: 1963118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.